← Back to Search

Behavioural Intervention

rtACS Stimulation for Glaucoma

N/A
Waitlist Available
Led By Heather Livengood, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline

Summary

This trial tests a new electric current treatment for people with glaucoma to improve their vision and quality of life by stimulating underperforming parts of their eyes and brain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Humphrey Visual Field Analyzer Score
Change in Macular Ganglion Cell-Inner Plexiform Layer Thickness
Change in Minnesota Low Vision Reading Test (MNRead): Reading Acuity Score
+17 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: rtACS Stimulation GroupExperimental Treatment1 Intervention
Group II: Sham Intervention GroupPlacebo Group1 Intervention
Sham stimulation looks like rtACS, but is not active rtACS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
rtACS Stimulation
2017
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,403 Previous Clinical Trials
855,108 Total Patients Enrolled
7 Trials studying Glaucoma
5,359 Patients Enrolled for Glaucoma
Heather Livengood, PhDPrincipal InvestigatorNYU Langone Health
Joel Schuman, MD, FACSPrincipal InvestigatorNYU Langone Health
~2 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top